Current treatment options for pancreatic carcinoma.

Castellanos E, Berlin J, Cardin DB
Curr Oncol Rep. 2011 13 (3): 195-205

PMID: 21491194 · DOI:10.1007/s11912-011-0164-1

Pancreas cancer is a significant cause of cancer mortality; therefore, the development of early diagnostic strategies and effective treatment is essential. Improvements in imaging technology, as well as use of biomarkers such as CA 19-9, are changing the way that pancreas cancer is diagnosed and staged. Although progress in treatment for pancreas cancer has been incremental, development of combination therapies involving both chemotherapeutic and biologic agents is ongoing. This article reviews current strategies in the diagnosis and treatment of resectable and advanced pancreas cancer.

MeSH Terms (12)

Biomarkers, Tumor CA-19-9 Antigen Carcinoma Chemotherapy, Adjuvant Combined Modality Therapy Deoxycytidine ErbB Receptors Humans Neoadjuvant Therapy Neoplasm Staging Pancreatic Neoplasms Positron-Emission Tomography

Connections (2)

This publication is referenced by other Labnodes entities: